Haemonetics' GAAP net income for fiscal year 2022 was $43.375 million, down 45.4% from $79.469 million in the prior year. Revenue increased 14.1% to $993.196 million from $870.463 million a year earlier.

Haemonetics' GAAP net income for 9 months of fiscal year 2022 was $33.634 million, down 2.7 times from $90.51 million in the prior year. Revenue increased 12.8% to $728.194 million from $645.434 million a year earlier.

Haemonetics' GAAP net income for 6M 2022 fiscal year was $10.402 million, down 5.7 times from $58.628 million in the previous year. Revenue increased 15.6% to $468.425 million from $405.063 million a year earlier.

Haemonetics' GAAP loss for 3M 2022 fiscal year was $4.454 million, compared to a profit of $10.527 million in the previous year. Revenue increased 16.8% to $228.528 million from $195.577 million a year earlier.